Evidence map›Paper›PMID 22034919›Full record

ArticleBMC biology2011

Sumo-dependent substrate targeting of the SUMO protease Ulp1.

Zachary C Elmore, Megan Donaher, Brooke C Matson, Helen Murphy, Jason W Westerbeck, Oliver Kerscher

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Zachary C ElmoreBiology Department, The College of William & Mary, ISC3047, 540 Landrum Drive, Williamsburg, VA 23185, USA.
Megan Donaher
Brooke C Matson
Helen Murphy
Jason W Westerbeck
Oliver Kerscher
William & Mary · USWilliams (United States) · US

Funding

Role of the SUMO Protease Ulp1 in Cell Cycle ProgressionR15GM085792 · NIGMS · COLLEGE OF WILLIAM AND MARY · PI KERSCHER, OLIVER NONE · 2008 to 2010
$257k
Howard Hughes Medical InstituteNIGMS NIH HHS R15 GM085792NIGMS NIH HHS R15-GM085792
6 · The paper itself

Abstract

backgroundIn the yeast Saccharomyces cerevisiae, the essential small ubiquitin-like modifier (SUMO) protease Ulp1 is responsible for both removing SUMO/Smt3 from specific target proteins and for processing precursor SUMO into its conjugation-competent form. Ulp1 localizes predominantly to nuclear pore complexes but has also been shown to deconjugate sumoylated septins at the bud-neck of dividing cells. How Ulp1 is directed to bud-neck localized septins and other cytoplasmic deconjugation targets is not well understood.

resultsUsing a structure/function approach, we set out to elucidate features of Ulp1 that are required for substrate targeting. To aid our studies, we took advantage of a catalytically inactive mutant of Ulp1 that is greatly enriched at the septin ring of dividing yeast cells. We found that the localization of Ulp1 to the septins requires both SUMO and specific structural features of Ulp1's catalytic domain. Our analysis identified a 218-amino acid, substrate-trapping mutant of the catalytic domain of Ulp1, Ulp1(3)(C580S), that is necessary and sufficient for septin localization. We also used the targeting and SUMO-binding properties of Ulp1(3)(C580S) to purify Smt3-modified proteins from cell extracts.

conclusionsOur study provides novel insights into how the Ulp1 SUMO protease is actively targeted to its substrates in vivo and in vitro. Furthermore, we found that a substrate-trapping Ulp1(3)(C580S) interacts robustly with human SUMO1, SUMO2 and SUMO2 chains, making it a potentially useful tool for the analysis and purification of SUMO-modified proteins.

Indexed as

BiocatalysisCatalytic DomainCysteine EndopeptidasesMembrane Transport ProteinsMutant ProteinsNuclear EnvelopeProtein BindingProtein TransportReceptors, Cytoplasmic and NuclearSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSeptinsSmall Ubiquitin-Related Modifier ProteinsStructure-Activity RelationshipSubstrate SpecificitySumoylationCysteine EndopeptidasesMembrane Transport ProteinsMutant ProteinsPSE1 protein, S cerevisiaeReceptors, Cytoplasmic and NuclearSaccharomyces cerevisiae ProteinsSeptinsSmall Ubiquitin-Related Modifier ProteinsUlp1 protease

Identifiers

PMID22034919
PMCPMC3216068
OpenAlexW2152923131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.